Center Director, Administrative Core Co -Director, and P.I. for Methods for Tobacco Exposure Reduction

Contact information:
Medical School: Department of Psychiatry
University of Minnesota
-OR-
Tobacco Use Research Center
2701 University Avenue SE
Suite 201
Minneapolis, MN 55414
Office: (612) 627-1808
hatsu001@umn.edu

Dorothy Hatsukami, Ph.D. is currently Professor of Psychiatry and Adjunct Professor of Psychology and of Epidemiology at the University of Minnesota, and Director of the Tobacco Use Research Programs. She has conducted research in the areas of nicotine addiction and treatment of nicotine addiction, among a general population of adult smokers and adolescents. She has also conducted research in the area of smokeless tobacco. She is currently a Principal Investigator of one of the seven NIH funded Transdisciplinary Tobacco Use Research Centers (TTURC). The research focus of this TTURC is on methods and understanding mechanism associated with reducing tobacco toxin exposure. She is a co-recipient of the Ove Ferno award for her research on tobacco dependence. Because of her expertise, she has served on a number of national committees including the National Advisory Council for Substance Abuse and Mental Health Services Administration, National Advisory Council on Drug Abuse, the Interagency Committee for Smoking and Health, Drug Control Research, Data, and Evaluation Committee for the Office of National Drug Control Policy, the Institute of Medicine and was on the Scientific Board of Counselors for the Intramural Research Program of NIDA. She has served on many advisory panels for other United States federal, non-profit and international organizations. She is a past President of the Society on Research on Nicotine and Tobacco and a past President of the College on Problems of Drug Dependence.

Selected Recent Publications

1. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, and Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research. 2006;8(4):599-622.
2. Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, and Leischow S. Methods to assess potential reduced exposure products. Nicotine & Tobacco Research. 2005;7(6):827-844.
3. Hatsukami DK, Kotlyar M, Allen S, Jensen J, Li S, Le C, and Murphy S. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128(4):2528-2537.
4. Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A, Horwith G, and Pentel PR. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clinical Pharmacology and Therapeutics. 2005;78(5):456-467.
5. Hatsukami DK, Henningfield JE, and Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annual Review of Public. 2004;25:377-395.
6. Hatsukami DK, Lemmonds C, and Tomar SL. Smokeless tobacco use: harm reduction or induction approach? Preventive Medicine. 2004;38(3):309-317.
7. Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, and Hecht SS. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Journal of the National Cancer Institute. 2004;96(11):844-852.
8. Hatsukami, D.K., Lemmonds, C. & Tomar, S. (2004). Smokeless tobacco use: harm reduction or induction approach? Preventive Medicine, 38:309-317.
9. Hatsukami, D.K., Rennard, S., Patel, M.K., Kotlyar, M., Malcolm, R., Nides, M.A., Dozier, G., Bars, M.P. & Jamerson, B.D. (2004). Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. American Journal of Medicine, 116:151-157.
10. Hatsukami, D.K., Henningfield, J.E. & Kotlyar, M. (2004). Harm reduction approaches to reducing tobacco-related mortality. Annual Review of Public Health, 25:1-19..
11. Lemmonds, C.A., Mooney, M., Reich, B. & *Hatsukami, D. (2004). Characteristics of cigarette smokers seeking treatment for cessation vs. reduction. Addictive Behaviors, 29(2):357-364.
12. Baker, T.B., Hatsukami, D.K., Lerman, C., O'Malley, S.S., Shields, A.E. & Fiore, M.C. (2003). Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine & Tobacco Research, 5(Supplement 1):S89-S99.
13. Hanson, K., Allen, S., Jensen, S. & *Hatsukami, D. (2003). Treatment of adolescent smokers with the nicotine patch. Nicotine & Tobacco Research, 5(4):515-526
14. Hatsukami, D.K., Hecht, S.S., Hennrikus, D., Joseph, A.M. & Pentel, P.R. (2003).. Biomarkers of tobacco exposure or harm. Conference summary. Nicotine & Tobacco Research, 5:387-396.